DEVELOPMENT AND REGISTRATION. 4.1 As of the Sublicence Effective Date and subject always to Novartis’s retained rights to the Manufacturing Patent and the Patents (and those of its licensees), the Licensee shall have full control, responsibility (financial and otherwise) and authority over development, registration, importation, manufacture and commercialisation of the Products to be sold orsupplied by the Licensee in the Field in the Territory under this Agreement.
Appears in 4 contracts
Samples: Licence Agreement, Licence Agreement, Licence Agreement
